Update on the Management of Lymphomas and CLL
Saturday, November 17, 2012
7:30 am – 3:45 pm
Dana-Farber Cancer Institute
44 Binney Street, 16th floor
Smith Family Room, Room 1620
Boston, MA
Offered by Dana-Farber/Brigham and Women's Cancer Center and Harvard Medical School Department of Continuing Education
Quicklinks
Course Overview | Agenda | Faculty
Credits | Registration Information | Directions & Parking
Course Overview
This course is designed to provide hematologists, oncologists, internists and other interested clinicians with an update on the latest developments in diagnosing and treating lymphomas and related disorders. Through lectures, case-based presentations and Q&A, participants will learn about emerging new drugs and drug combinations as well as how to incorporate these new treatments into daily practice.
At the conclusion of this course, attendees will be able to: provide an overview and highlight the recent advances in lymphoma and CLL to achieve better patient outcomes; and recognize appropriate management and treatment options for hematologic malignancies and how to apply these approaches in routine clinical practice.
This course has been designed to enhance the following Accreditation Council for Graduate Medical Education competencies:
- Patient care that is compassionate, appropriate and effective for the treatment of health problems and the promotion of health
- Medical knowledge
- Practice-based learning and improvement that involves the investigation and evaluation of their own patient care, appraisal and assimilation of scientific evidence, and improvements in patient care
About the Lymphoma Program at Dana-Farber/Brigham and Women's Cancer Center
The Adult Lymphoma Program within the Hematologic Oncology Treatment Center provides specialized treatment for the many varieties of lymphoid malignancies, including Non-Hodgkin lymphoma (NHL), Hodgkin lymphoma, chronic lymphocytic leukemia (CLL), B-cell neoplasms, and T-cell neoplasms. Our team has extensive experience caring for patients with lymphoma and collaborates closely with our transplant experts when patients require stem cell transplantation. We are also actively involved in clinical research to make therapies more effective, specific and less toxic. Read more.
Agenda
7:30 am
Continental Breakfast and Registration Check-in
8:15 am
Welcome
Arnold S. Freedman, MD
8:30 am
Update on Follicular Lymphoma
Arnold S. Freedman, MD
9:15 am
Management of CLL
Jennifer R. Brown, MD, PhD
10:00 am
Update in Cutaneous Lymphoma
David C. Fisher, MD
10:45 am
Case Discussions and Q&A for Indolent Lymphomas
11:15 am
Break
11:30 am
Management of Peripheral T-Cell Lymphomas
Eric P. Jacobsen, MD
12:15 pm
Lunch
1:00 pm
Biology of Diffuse Large B-Cell Lymphoma
Margaret A. Shipp, MD
1:45 pm
Management of Aggressive Lymphoma
Philippe Armand, MD, PhD
2:30 pm
Case Discussions and Q&A for Aggressive Lymphomas
3:00 pm
Panel, Case Discussions on Hodgkin's Lymphoma
George P. Canellos, MD; Ann S. LaCasce, MD; Peter M. Mauch, MD
Faculty
Arnold S. Freedman, MD, Course Co-Director
Clinical Director, Lymphoma Program
Dana-Farber/Brigham and Women's Cancer Center;
Associate Professor of Medicine, Harvard Medical School
Margaret A. Shipp, MD, Course Co-Director
Chief, Division of Hematologic Neoplasia; Director, Lymphoma Program
Dana-Farber/Brigham and Women's Cancer Center;
Professor of Medicine, Harvard Medical School
Philippe Armand, MD, PhD
Hematologist/Oncologist
Dana-Farber/Brigham and Women's Cancer Center;
Assistant Professor of Medicine, Harvard Medical School
Jennifer R. Brown, MD, PhD
Director, Chronic Lymphocytic Leukemia Center
Dana-Farber/Brigham and Women's Cancer Center;
Assistant Professor of Medicine, Harvard Medical School
George P. Canellos, MD
Hematologist/Oncologist
Dana-Farber/Brigham and Women's Cancer Center;
William Rosenberg Professor of Medicine, Harvard Medical School
David C. Fisher, MD
Hematologist/Oncologist
Dana-Farber/Brigham and Women's Cancer Center;
Assistant Professor of Medicine, Harvard Medical School
Eric P. Jacobsen, MD
Director, Ambulatory Service for Hematologic Malignancies
Dana-Farber/Brigham and Women's Cancer Center;
Assistant Professor of Medicine, Harvard Medical School
Ann S. LaCasce, MD
Director, Dana-Farber/Partners CancerCare Fellowship Program, Dana-Farber/Brigham and Women's Cancer Center;
Assistant Professor of Medicine, Harvard Medical School
Peter M. Mauch, MD
Radiation Oncologist
Dana-Farber/Brigham and Women's Cancer Center;
Professor of Radiation Oncology, Harvard Medical School
HMS Disclosure Policy
Harvard Medical School (HMS) adheres to all ACCME Essential Areas, Standards, and Policies. It is HMS's policy that those who have influenced the content of a CME activity (e.g. planners, faculty, authors, reviewers and others) disclose all relevant financial relationships with commercial entities so that HMS may identify and resolve any conflicts of interest prior to the activity. These disclosures will be provided in the activity materials along with disclosure of any commercial support received for the activity. Additionally, faculty members have been instructed to disclose any limitations of data and unlabeled or investigational uses of products during their presentations.
CME Credits
The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education to provide continuing education for physicians.
The Harvard Medical School designates this live activity for a maximum of 6.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Submit Your Case for Discussion at the CME
Course participants are invited to submit a challenging case for discussion by program faculty during the November 17 program. To submit your case, complete the attached form and email to kkupferberg@partners.org by October 15.
Registration Information
Registration Fee: $75.00 (non-refundable).
Registration fee includes continental breakfast, lunch, parking and course materials.
To register by mail: Send a completed registration form and payment by November 7 to:
Lymphoma CME
Attn: Kamira Wooten
450 Brookline Avenue, OS 381
Boston, MA 02215
If you have food allergies, or if you require accommodations such as an ASL interpreter, materials in alternative format or wheelchair access, please email kwooten@partners.org or call 800-553-3787.
Directions and Parking
This course will be held on the 16th floor, Room 1620 in the Dana Building at Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA. Complimentary parking is available in the Dana-Farber garage located at 1 Jimmy Fund Way. For directions, visit www.dana-farber.org/directions.
Once you have parked, please follow the posted signs to Dana 1620/Smith Family Room.
